ArcticZymes Technologies Q3 2020 Results
Tromsø, Norway, 22 October 2020 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 30.8 million (22.5) and an EBITDA of NOK 10.1 million (0.8) for the third quarter of 2020. Underlying growth continues.Highlights from Q3 2020 · Annual group sales exceed 100 MNOK for the first time · Gross profit for the Group improved 65% to NOK 26.0 million (Q3 2019: NOK 15.7 million) · ArcticZymes had Q3 sales of NOK 19.5 million growing by 63% (Q3 2019: NOK 12.0 million) · Biotec BetaGlucans had Q3 sales of NOK 11.2 million growing by 7% (Q3 2019: NOK 10.5 million) · Upsides